MedTrace Logo

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

NCT00477334 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 463

Last updated 2011-03-28

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of single-day famciclovir episodic treatment in Black patients with recurrent genital herpes

Conditions

  • Genital Herpes

Interventions

DRUG

Famciclovir

oral; two 500 mg tablets twice a day; single day treatment

DRUG

Placebo

oral; two tablets twice a day; single day treatment

Sponsors & Collaborators

Principal Investigators

  • Dalu Mohammed, Dr · Clayton Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States
  • South Africa

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00477334 on ClinicalTrials.gov